Tidal Investments’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
Tidal Investments's CSTL Position: Q3 2026 in Review
Tidal Investments increased its Castle Biosciences (CSTL) stake by 3.6% in Q3 2026, buying an estimated $23.9K and bringing the position to 22,979 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #1840.
Tidal Investments first reported a position in CSTL in Q2 2026 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.
- Tidal Investments held 22,979 shares of Castle Biosciences worth $816K as of Q3 2026.
- Tidal Investments bought 793 Castle Biosciences shares in Q3 2026, an estimated $23.9K.
- Castle Biosciences made up ﹤0.01% of Tidal Investments's portfolio in Q3 2026, its #1840 holding.
- Tidal Investments first reported a position in Castle Biosciences in Q2 2026 and has held it in 2 quarters since.
- 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.
Based on Tidal Investments's 13F filing for Q3 2026, filed 13 Nov 2026.